Antibody response in psoriatic patients treated with 6-azauridine-triacetate.
D000917:Antibody Formation / Q000187:drug effects*; D001380:Azauridine / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D007114:Immunization; D007117:Immunization, Secondary; D008875:Middle Aged; D011565:Psoriasis / Q000188:drug therapy* / Q000276:immunology; D013223:Statistics as Topic; D013742:Tetanus / Q000276:immunology; D013743:Tetanus Antitoxin; D013997:Time Factors
D013743:Tetanus Antitoxin; D001380:Azauridine